Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification

2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3389/fphar.2025.1642830
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Abstract Background This study presents a comprehensive analysis of antibiotic consumption in a dispensary hospital in Aktobe, Kazakhstan, from 2019 to 2021, utilizing the World Health Organization's (WHO) "Access, Watch, and Reserve" (AWaRe) classification. Objective The primary objective of this study was to assess the patterns of antibiotic use in the hospital and to determine the extent to which the AWaRe classification could be effectively implemented in Kazakhstan to guide optimal antibiotic use and establish performance targets. Methods The study analyzed data on the consumption of systemic antibacterial drugs in the dispensary hospital from 2019 to 2021. The usage of antibiotics was classified according to the WHO's AWaRe classification, which categorizes antibiotics into three groups: "Access," "Watch," and "Reserve." Results The study revealed a concerning trend in the irrational consumption of systemic antibiotics. There was a notable decrease in the use of "Access" antibiotics from 39.13% in 2019 to 22% in 2021, which is contrary to WHO recommendations. Conversely, the use of "Watch" antibiotics increased, particularly during the COVID-19 pandemic. The most commonly used antibiotics were cephalosporins, fluoroquinolones, and carbapenems. Conclusion The findings underscore the urgent need for implementing the AWaRe classification database in Kazakhstan to guide optimal antibiotic use, set performance targets, and establish a working group to monitor and control the prescription and use of antibacterial drugs. This study contributes to the global understanding of antibiotic consumption patterns and the challenges faced in adhering to international guidelines, particularly in the context of a pandemic.